# Cangene BioPharma, LLC, Rockville, MD – FDA Inspections

Source: https://www.keypedia.com/companies/cangene-biopharma-llc/d685e3d6-8e3c-4950-b2f9-9b3aaea0df9d

> Inspection records and compliance data for Cangene BioPharma, LLC in Rockville, Maryland. 3 FDA inspections on record, 2 Form 483s, 1 warning letter, last inspected February 16, 2019.

---

## Details

- Name: Cangene BioPharma, LLC
- FEI Number: 3008934776
- Address Line 1: 9920 Medical Center Dr
- City: Rockville
- State: Maryland
- Zip Code: 20850-3447
- Country Name: United States
- Address: 9920 Medical Center Dr, Rockville, Maryland 20850-3447, United States
- Country: United States

## Related Documents

- [483 - Cangene BioPharma, LLC - Unknown Date](https://www.keypedia.com/records/483/cangene-biopharma-llc/6e713878-515e-4ad7-8897-24187a6d5234) — source: FDA, date: Invalid Date
- [WARNING_LETTER - Cangene BioPharma, LLC - 2022-02-18](https://www.keypedia.com/records/warning_letter/cangene-biopharma-llc/fff7ba55-eeac-4a7b-be09-c1d6e3e6ae1e) — source: FDA, date: February 18, 2022
- [EIR - Cangene BioPharma, LLC - 2019-05-10](https://www.keypedia.com/records/eir/cangene-biopharma-llc/00b51ddf-d6b3-43c2-a590-b1f008c94e9b) — source: FDA, date: May 10, 2019
- [EIR - Cangene BioPharma, LLC - 2019-02-16](https://www.keypedia.com/records/eir/cangene-biopharma-llc/fe8a12b1-889e-47a2-afee-0296ac4d1d04) — source: FDA, date: February 16, 2019
- [FDA Inspection 1084658 - Cangene BioPharma, LLC - 2019-02-16](https://www.keypedia.com/records/fda_inspections/cangene-biopharma-llc/ee254e98-f217-41a7-a3d2-7d505cf22b5c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 16, 2019
- [EIR - Cangene BioPharma, LLC - 2018-06-13](https://www.keypedia.com/records/eir/cangene-biopharma-llc/56573b2c-1cff-4869-9495-d65f6978f962) — source: FDA, date: June 13, 2018
- [FDA Inspection 1012266 - Cangene BioPharma, LLC - 2017-03-22](https://www.keypedia.com/records/fda_inspections/cangene-biopharma-llc/2dd7597d-ab49-4a1e-9cda-cdc92f96614e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 22, 2017
- FDA Inspection 928289 - Cangene BioPharma, LLC - 2015-04-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 17, 2015

## Related Companies

- [Novartis Gene Therapies, Inc.](https://www.keypedia.com/companies/novartis-gene-therapies-inc/58c140f1-7389-4053-a757-b61650a3a86a)
- [Biovex, Inc.](https://www.keypedia.com/companies/biovex-inc/796f9894-ce55-4789-9665-b70237ceb306)
- [Lux Therapeutics LLC](https://www.keypedia.com/companies/lux-therapeutics-llc/95b5496d-558f-4e0b-8058-06fa8fba5c7d)
- [Abington Memorial Hospital](https://www.keypedia.com/companies/abington-memorial-hospital/6a3d9aaf-54c3-4e7f-a644-9d0788dc89f0)
- [Wayne Farnsworth, MD](https://www.keypedia.com/companies/wayne-farnsworth-md/26ddf1b3-06a8-43f9-a894-2976543880d4)
- [Chara Biologics, Inc.](https://www.keypedia.com/companies/chara-biologics-inc/1dcf1d04-8a40-4431-8236-97461bcf74eb)
- [Xo Biologix](https://www.keypedia.com/companies/xo-biologix/733af757-6b13-401a-8abd-d8b5628ffd76)
- [Octapharma Plasma, Inc.](https://www.keypedia.com/companies/octapharma-plasma-inc/1250700e-204f-4fe1-91f2-0500280f5abc)
- [Ultragenyx Pharmaceutical Inc.](https://www.keypedia.com/companies/ultragenyx-pharmaceutical-inc/eced36f4-f37f-4271-b0fa-cad0b7de872b)
- [Hemacare Corp](https://www.keypedia.com/companies/hemacare-corp/9680df30-2873-4af7-ad2c-81f6aae55609)

## Related Officers

- [Gene D. Arcy](https://www.keypedia.com/people/gene-d-arcy/a2def947-65fb-4056-84e2-1f89cf944cf0)
- [company_representative](https://www.keypedia.com/people/john-decote/1baee9ec-10c9-49c7-ace9-72d870384c12)
- [company_representative](https://www.keypedia.com/people/jason-zoldus/2afc97bd-4f3c-4409-b6bb-ab0f88e3d78d)
- [recipient](https://www.keypedia.com/people/henry-schea/4c21e6ea-9fd2-4cee-a0e2-4748781cc192)